美国芯片制造商英伟达（Nvidia）宣布对四家法国科技公司进行少数股权投资，其中包括医疗预约平台Doctolib，以此扩大其在欧洲快速增长的人工智能领域的影响力。
American chipmaker Nvidia has announced minority investments in four French technology companies, including the medical appointment platform Doctolib, as it expands its presence in Europe’s fast-growing artificial intelligence sector.
英伟达首席执行官黄仁勋（Jensen Huang）周二在巴黎宣布了这一计划，称其旨在“在欧洲发起人工智能革命”。英伟达及法国公司均未披露所持股份的规模或价值。
Nvidia chief executive Jensen Huang announced the plans in Paris on Tuesday, saying they were intended to “launch the artificial intelligence revolution in Europe”. Neither Nvidia nor the French companies disclosed the size or value of the stakes.
Doctolib是法国最知名的科技公司之一，表示英伟达将成为其少数股东，但不会在其董事会中占据席位。该平台在上一轮融资中估值达36亿欧元，可让患者预约医疗服务并存储健康记录。
Doctolib, one of France’s best-known technology companies, said Nvidia would become a minority shareholder without a seat on its board. The platform, valued at €3.6 billion in its last funding round, allows patients to book medical appointments and store health records.
首席执行官斯坦尼斯拉斯·尼奥-夏托（Stanislas Niox-Château）表示，这笔投资将加速Doctolib的招聘及其内部人工智能（AI）模型的开发。这些模型旨在为患者提供个人健康助手，为医护人员提供助手，覆盖行政和临床任务。
Chief executive Stanislas Niox-Château said the investment would accelerate recruitment and the development of Doctolib’s in-house artificial intelligence (AI) models. These are intended to power a personal health assistant for patients and assistants for medical staff, covering administrative and clinical tasks.
随着新透明度规则生效，欧盟正加强人工智能监管。Doctolib将使用英伟达的芯片、算力和开放软件，同时寻求保留对其模型和患者数据的控制权，而非依赖OpenAI或Anthropic等美国人工智能供应商。
EU steps up AI regulation as new transparency rules come into effect Doctolib will use Nvidia’s chips, computing capacity and open software, while seeking to retain control of its models and patient data rather than relying on US AI providers such as OpenAI or Anthropic. The company launched a research programme in August using data from its 50 million users to improve patient pathways, a move criticised by rights groups.
该公司于8月启动了一项研究计划，利用其5000万用户的数据改善患者就医路径，此举曾引起权利团体的批评。
The Ligue des droits de l’Homme warned in a statement on 16 July that "health data... containing details of diagnoses, medical treatments and health histories, carry a significant risk of stigmatisation, discrimination and abusive profiling".
法国人权联盟（Ligue des droits de l’Homme）在7月16日的一份声明中警告称：“健康数据……包含诊断、医疗治疗和健康史的细节，存在被污名化、歧视和滥用画像的重大风险”。
Nvidia also announced investments in Genesis AI, a Franco-American robotics start-up; Pigment, which develops AI-assisted business planning software; and Entalpic, which uses generative AI to discover new industrial materials.
英伟达还宣布对法美机器人初创公司Genesis AI、开发AI辅助商业规划软件的Pigment，以及利用生成式AI发现新型工业材料的Entalpic进行投资。
Huang said Nvidia had invested at least $8 billion in Europe last year and plans to spend a further $2bn this year.
黄仁勋表示，英伟达去年在欧洲投资至少80亿美元，并计划今年再投入20亿美元。
He later met President Emmanuel Macron at the Elysée Palace to discuss Nvidia’s investments in France’s AI ecosystem, open-source technology and AI security.
随后，他在爱丽舍宫会见了法国总统埃马纽埃尔·马克龙，讨论了英伟达在法国人工智能生态系统、开源技术和人工智能安全方面的投资。
"Jensen Huang knows it," Macron wrote in a social media post.
马克龙在社交媒体上写道：“黄仁勋知道这一点。”“法国是欧洲人工智能最具吸引力的国家……英伟达正在投资法国公司，并承诺支持我们的法德倡议，以在欧洲发展开放式研究。”
"France is Europe’s most attractive country for artificial intelligence... Nvidia is investing in French companies and committing to support our Franco-German initiative to develop open research in Europe."